JI
Sen. James Inhofe (R-OK) bought $15K-$50K of EDIT stock
James Inhofe, U.S. Senator (R-OK), disclosed a purchase of Editas Medicine, Inc. (EDIT) stock worth $15K-$50K in a STOCK Act filing on Nov 8, 2017.
The trade happened on Oct 19, 2017, 20 days before it was made public.
EDIT has moved -90.1% since the trade date, from $23.95 to $2.38 (Nov 11, 2026 close).
- Traded
- Oct 19, 2017
- Disclosed
- Nov 8, 2017
- Filing delay
- 20 days
- Price since
- -90.1%
- Source
- STOCK Act disclosure